Clal Biotechnologies TASE IPO Raising money in TASE is not easy these days, even when you have Teva backing you up. Clal reduced the IPO size from 250M to 200M shekels.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.